In January, the Therapeutic Goods Administration (TGA) approved 10,596 SAS-B applications, up from 9,375 in December 2023. Queensland led in medicinal cannabis approvals, with 4,067 applications, followed by Victoria with 3,823. High-THC medicines made up nearly half the approvals, and chronic pain was the most treated condition. Oral solutions were the most popular format.
Read the full story here
Written by: Martin Lane
Published on February 12, 2024 at 11:09AM
Source: Cannabiz (opens in new tab)